Investors Press Releases May 14 2026 Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab Read More Apr 16 2026 Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function Read More Apr 14 2026 Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress Read More btn News View All Events & Presentations Dec 16 2025 at 8:30 AM EST Dec 16 2025 at 8:30 AM EST Annual General Meeting 2025 Read More Dec 12 2024 at 8:30 AM EST Dec 12 2024 at 8:30 AM EST Annual General Meeting 2024 Read More Dec 14 2023 at 8:30 AM EST Dec 14 2023 at 8:30 AM EST Annual General Meeting 2023 Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2025 721.5 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2024 1.4 MB btn ARs View All Annual General Meeting 2025 AGM Results 60.5 KB btn AGM View All Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
May 14 2026 Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab Read More
Apr 16 2026 Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function Read More
Apr 14 2026 Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress Read More